Security Snapshot

GH Research PLC - Ordinary Shares, nominal value $0.025 per share (GHRS) Institutional Ownership

CUSIP: G3855L106

13F Institutional Holders and Ownership History from Q2 2021 to Q2 2026

Latest Period

Q2 2026

Institutions Reporting

63

Shares (Excl. Options)

51,499,871

Price

$26.88

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0.01%
Share change
+3,911,908
Value change
+$149,026,278
Number of holders
63
Issuer context Names, identifiers, and filing context for this profile. 2 identity fields
Shares outstanding
68,721,699
SEC-reported price per share
$27.96
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • GHRS - GH Research PLC - Ordinary Shares, nominal value $0.025 per share is tracked under CUSIP G3855L106.
  • 63 institutions reported positions in Q2 2026.
  • 6 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 54 to 63 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from $668,548,105 to $1,384,353,041.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 63 institutions filings for Q2 2026.

Open SEC evidence

Security key

G3855L106

Latest holder period

Q2 2026

13F holders

63

13D/G owners

6

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
6
Security
GHRS
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Lynx1 Capital Management LP 19% +11% $356,649,814 +$67,225,000 13,263,288 +23% Lynx1 Capital Management LP 30 Jun 2026
BIOTECHNOLOGY VALUE FUND L P 14% $84,128,095 8,827,712 BVF PARTNERS L P/IL 31 Mar 2025
RTW INVESTMENTS, LP 8.9% $52,412,799 5,499,769 RTW Investments, LP 31 Mar 2025
FMR LLC 8.2% +19% $81,728,927 +$13,523,168 5,092,145 +20% FMR LLC 30 Jun 2025
RA CAPITAL MANAGEMENT, L.P. 7.1% -44% $131,685,224 -$74,741,158 4,897,182 -36% RA Capital Management, L.P. 12 Aug 2026
Terwey Theis H 2.9% -59% $25,515,004 -$41,593,509 1,784,266 -62% Terwey Theis H 30 Sep 2025

As of 30 Jun 2026, 63 institutional investors reported holding 51,499,871 shares of GH Research PLC - Ordinary Shares, nominal value $0.025 per share (GHRS). This represents 75% of the company’s total 68,721,699 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
74%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Lynx1 Capital Management LP 19% 13,263,288 +23% 41% $356,517,181
BVF INC/IL 13% 8,650,158 0% 5.9% $232,516,247
RA CAPITAL MANAGEMENT, L.P. 11% 7,636,813 -0.52% 1.8% $205,277,533
FMR LLC 8.7% 5,977,045 +16% 0.01% $160,662,969
RTW INVESTMENTS, LP 8.6% 5,933,815 0% 1.4% $159,500,947
Deep Track Capital, LP 4.9% 3,333,334 1.3% $89,600,018
Avoro Capital Advisors LLC 2.6% 1,800,000 0% 0.43% $48,384,000
Foresite Capital Management VI LLC 1.4% 940,493 +198% 3.9% $25,280,452
Jefferies Financial Group Inc. 1% 712,300 0% 0.18% $19,146,624
BlackRock, Inc. 0.7% 480,287 +5.4% 0% $12,910,116
UBS Group AG 0.69% 477,408 +16% 0% $12,832,727
MILLENNIUM MANAGEMENT LLC 0.47% 323,399 -66% 0.01% $8,692,965
BRAIDWELL LP 0.3% 207,240 0.21% $5,570,611
BOOTHBAY FUND MANAGEMENT, LLC 0.29% 202,103 -29% 0.1% $5,432,529
JANE STREET GROUP, LLC 0.25% 169,951 0% $4,568,283
HighVista Strategies LLC 0.23% 158,770 -26% 0.97% $4,267,737
Trexquant Investment LP 0.22% 153,767 +120% 0.03% $4,133,257
GOLDMAN SACHS GROUP INC 0.22% 148,673 +232% 0% $3,996,330
XTX Topco Ltd 0.13% 86,986 +67% 0.03% $2,338,184
CITADEL ADVISORS LLC 0.13% 85,952 +31% 0% $2,310,390
AdvisorShares Investments LLC 0.1% 71,267 +6.3% 0.23% $1,915,657
CenterBook Partners LP 0.1% 69,436 -68% 0.09% $1,866,440
HRT FINANCIAL LP 0.1% 65,375 0% $1,757,000
MORGAN STANLEY 0.08% 52,218 +102% 0% $1,403,620
Point72 Asset Management, L.P. 0.07% 50,882 0% $1,367,708

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
21
Latest
Q2 2026
Rows shown
1-21 of 21
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q2 51,499,871 $1,384,353,041 +$149,026,278 $26.88 63
2026 Q1 47,551,006 $668,548,105 +$17,053,566 $14.06 54
2025 Q4 46,564,278 $591,366,552 +$19,014,477 $12.70 53
2025 Q3 44,533,428 $618,134,274 +$14,411,795 $14.30 47
2025 Q2 43,554,151 $530,925,463 +$12,435,267 $12.19 37
2025 Q1 42,619,365 $470,078,472 +$132,646,472 $11.03 35
2024 Q4 30,702,522 $214,921,353 +$703,147 $7.00 31
2024 Q3 30,520,551 $204,184,484 +$470,359 $6.69 28
2024 Q2 30,425,860 $354,768,061 +$9,911,656 $11.66 28
2024 Q1 29,598,383 $315,521,410 +$9,696,487 $10.66 32
2023 Q4 29,604,263 $171,708,593 +$1,756,706 $5.80 35
2023 Q3 29,004,299 $291,487,763 -$8,205,765 $10.05 29
2023 Q2 29,634,294 $351,618,806 -$693,689 $11.86 34
2023 Q1 29,693,376 $237,250,217 -$9,782,816 $7.99 29
2022 Q4 30,892,511 $299,454,602 -$7,759,406 $9.72 32
2022 Q3 31,599,032 $367,179,200 -$9,454,337 $11.62 33
2022 Q2 32,559,951 $324,989,656 +$3,737,200 $9.98 33
2022 Q1 32,084,312 $586,822,000 +$37,199,278 $18.29 30
2021 Q4 30,046,921 $700,993,000 +$26,953,821 $23.33 29
2021 Q3 28,509,902 $625,158,000 +$21,272,275 $22.06 29
2021 Q2 27,592,126 $593,693,000 +$593,693,000 $21.73 34
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .